Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |